British Thoracic Society study of cryptogenic fibrosing alveolitis: Current presentation and initial management

Thorax

Volumn 52, Issue 1, 1997, Pages 38-44

  Johnston, I D A ^a   Prescott, R J ^c   Chalmers, J C ^c   Rudd, R M ^b  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b LONDON CHEST HOSPITAL   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

British Thoracic Society; cryptogenic fibrosing alveolitis; presentation; treatment

Indexed keywords

ADULT; AGE; AGED; ARTICLE; DUST EXPOSURE; FEMALE; FIBROSING ALVEOLITIS; HUMAN; LUNG BIOPSY; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PHYSICIAN; PRIORITY JOURNAL; QUESTIONNAIRE;

EID: 0031013772     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.52.1.38     Document Type: Article

References (16)

1. Johnston I, Britton J, Kinnear W, Logan R. Rising mortality from cryptogenic fibrosing alveolitis. BMJ 1990;301: 1017-21.
2. Hubbard R, Johnston IDA, Coultas D, Britton J. Mortality rates from cryptogenic fibrosing alveolitis in seven countries. Thorax 1996;51:711-6.
3. Johnston IDA, Gomm SA, Kalra S, Woodcock AA, Evans CC, Hind CRK. The management of cryptogenic fibrosing alveolitis in three regions of the United Kingdom. Eur Respir J 1993;6:891-3.
4. Hubbard R, Lewis S, Richards K, Johnston I, Britton J. Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis. Lancet 1996;347: 284-9.
5. Tukiainen P, Taskinen E, Holsti P, Korhola O, Valle M. Prognosis of cryptogenic fibrosing alveolitis. Thorax 1983; 38:349-55.
6. Turner-Warwick M, Burrows B, Johnson A. Cryptogenic fibrosing alveolitis: clinical features and their influence on survival. Thorax 1980;35:171-80.
7. Carrington CB, Gaensler EA, Coutu RE, Fitzgerald MX, Gupta RG. Natural history and treated course of usual and desquamative interstitial pneumonia. N Engl J Med 1978;298:801-9.
8. Hance AJ, Crystal RG. Idiopathic pulmonary fibrosis. In: Flenley DC, Petty TL, eds. Recent advances in respiratory medicine 3. Edinburgh: Churchill Livingstone, 1983.
9. Turner-Warwick M. Infiltrative and interstitial lung disease. In: Brewis RAL, Gibson GJ, Geddes DM, eds. Respiratory medicine. London: Bailliere Tindall, 1900.
10. Standardised Lung Function Testing. Official Statement of the European Respiratory Society. Eur Respir J 1993;6: (Suppl 16).
11. Du Bois RM. Diffuse lung disease: an approach to management. BMJ 1994;309:175-9.
12. Honma K, Chiyotani K. Diffuse interstitial fibrosis in non-asbestos pneumoconiosis a pathological study. Respiration 1993;60:120-6.
13. Gaensler EA, Jederlinic PJ, Churg A. Idiopathic pulmonary fibrosis in asbestos exposed workers. Am Rev Respir Dis 1991;144:689-96.
14. Stack BHR, Choo-Kang YFJ, Heard BE. The prognosis of cryptogenic fibrosing alveolitis. Thorax 1972;27:535-42.
15. Smith C, Feldman C, Levy H, Kallenbach JM, Zwi S. Cryptogenic fibrosing alveolitis. A study of an indigenous African population. Respiration 1990;57:364-71.
16. Wall CP, Gaensler EA, Carrington CB, Haves JA. Comparison of transbronchial and open lung biopsies in chronic infiltrative disease. Am Rev Respir Dis 1981;123:280-5.